Bone Biologics Corp Stock Technical Analysis

BBLGW Stock  USD 27.80  0.00  0.00%   
As of the 25th of December, Bone Biologics shows the Risk Adjusted Performance of 0.0526, standard deviation of 23.73, and Mean Deviation of 5.38. Bone Biologics Corp technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices. Please confirm Bone Biologics Corp variance and skewness to decide if Bone Biologics Corp is priced correctly, providing market reflects its regular price of 27.8 per share. Given that Bone Biologics has total risk alpha of 0.2346, we suggest you to validate Bone Biologics Corp's prevailing market performance to make sure the company can sustain itself at a future point.

Bone Biologics Momentum Analysis

Momentum indicators are widely used technical indicators which help to measure the pace at which the price of specific equity, such as Bone, fluctuates. Many momentum indicators also complement each other and can be helpful when the market is rising or falling as compared to Bone
  
Bone Biologics' Momentum analyses are specifically helpful, as they help investors time the market using mark points where the market can reverse. The reversal spots are usually identified through divergence between price movement and momentum.
Bone Biologics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of Bone Biologics technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Bone Biologics trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Bone Biologics Corp Technical Analysis

Indicator
Time Period
Execute Indicator
The output start index for this execution was twenty with a total number of output elements of fourty-one. The Average True Range was developed by J. Welles Wilder in 1970s. It is one of components of the Welles Wilder Directional Movement indicators. The ATR is a measure of Bone Biologics Corp volatility. High ATR values indicate high volatility, and low values indicate low volatility.

Bone Biologics Corp Trend Analysis

Use this graph to draw trend lines for Bone Biologics Corp. You can use it to identify possible trend reversals for Bone Biologics as well as other signals and approximate when it will take place. Remember, you need at least two touches of the trend line with actual Bone Biologics price movement. To start drawing, click on the pencil icon on top-right. To remove the trend, use eraser icon.

Bone Biologics Best Fit Change Line

The following chart estimates an ordinary least squares regression model for Bone Biologics Corp applied against its price change over selected period. The best fit line has a slop of   0.57  , which may suggest that Bone Biologics Corp market price will keep on failing further. It has 122 observation points and a regression sum of squares at 12345.84, which is the sum of squared deviations for the predicted Bone Biologics price change compared to its average price change.

About Bone Biologics Technical Analysis

The technical analysis module can be used to analyzes prices, returns, volume, basic money flow, and other market information and help investors to determine the real value of Bone Biologics Corp on a daily or weekly bases. We use both bottom-up as well as top-down valuation methodologies to arrive at the intrinsic value of Bone Biologics Corp based on its technical analysis. In general, a bottom-up approach, as applied to this company, focuses on Bone Biologics Corp price pattern first instead of the macroeconomic environment surrounding Bone Biologics Corp. By analyzing Bone Biologics's financials, daily price indicators, and related drivers such as dividends, momentum ratios, and various types of growth rates, we attempt to find the most accurate representation of Bone Biologics's intrinsic value. As compared to a bottom-up approach, our top-down model examines the macroeconomic factors that affect the industry/economy before zooming in to Bone Biologics specific price patterns or momentum indicators. Please read more on our technical analysis page.
 2023 2024 (projected)
Payables Turnover0.0013410.001274
Days Of Inventory On Hand368.2327.29

Bone Biologics December 25, 2024 Technical Indicators

Most technical analysis of Bone help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Bone from various momentum indicators to cycle indicators. When you analyze Bone charts, please remember that the event formation may indicate an entry point for a short seller, and look at different other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

Bone Biologics December 25, 2024 Daily Trend Indicators

Traders often use several different daily volumes and price technical indicators to supplement a more traditional technical analysis when analyzing securities such as Bone stock. With literally thousands of different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.

Additional Tools for Bone Stock Analysis

When running Bone Biologics' price analysis, check to measure Bone Biologics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bone Biologics is operating at the current time. Most of Bone Biologics' value examination focuses on studying past and present price action to predict the probability of Bone Biologics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Bone Biologics' price. Additionally, you may evaluate how the addition of Bone Biologics to your portfolios can decrease your overall portfolio volatility.